Anti-GATA4 (phospho S105) antibody (ab5245)


  • Product name
    Anti-GATA4 (phospho S105) antibody
    See all GATA4 primary antibodies
  • Description
    Rabbit polyclonal to GATA4 (phospho S105)
  • Host species
  • Tested applications
    Suitable for: ICC/IF, EMSA, IHC-Fr, WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Dog
    Predicted to work with: Chicken, Human
  • Immunogen

    Synthetic peptide (Human) derived from a region of GATA 4 that contains serine 105.

  • Positive control
    • Phenylephrine (PE)-stimulated rat cardiomyocytes, transfected with mouse GATA 4.



Our Abpromise guarantee covers the use of ab5245 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use at an assay dependent concentration. PubMed: 19546173
EMSA Use at an assay dependent concentration.
IHC-Fr Use at an assay dependent concentration. PubMed: 22919071
WB Use a concentration of 0.1 - 1 µg/ml. Detects a band of approximately 45 kDa (predicted molecular weight: 46 kDa).


  • Function
    Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development (PubMed:24000169). Involved in bone morphogenetic protein (BMP)-mediated induction of cardiac-specific gene expression (By similarity). Binds to BMP response element (BMPRE) DNA sequences within cardiac activating regions (By similarity). Acts as a transcriptional activator of ANF in cooperation with NKX2-5 (By similarity). Promotes cardiac myocyte enlargement (PubMed:20081228). Required during testicular development (PubMed:21220346). May play a role in sphingolipid signaling by regulating the expression of sphingosine-1-phosphate degrading enzyme, spingosine-1-phosphate lyase (PubMed:15734735).
  • Involvement in disease
    Atrial septal defect 2
    Ventricular septal defect 1
    Tetralogy of Fallot
    Atrioventricular septal defect 4
    Testicular anomalies with or without congenital heart disease
    GATA4 mutations can predispose to dilated cardiomyopathy (CMD), a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
  • Sequence similarities
    Contains 2 GATA-type zinc fingers.
  • Post-translational
    Methylation at Lys-300 attenuates transcriptional activity.
  • Cellular localization
  • Information by UniProt
  • Database links
  • Alternative names
    • ASD2 antibody
    • GATA 4 antibody
    • GATA binding protein 4 antibody
    • GATA-binding factor 4 antibody
    • gata4 antibody
    • GATA4_HUMAN antibody
    • MGC126629 antibody
    • Transcription factor GATA 4 antibody
    • Transcription factor GATA-4 antibody
    • Transcription factor GATA4 antibody
    • VSD1 antibody
    see all


  • Extracts prepared from cardiomyocytes overexpressing wild-type GATA-4 (1-4 from left to right) stimulated with phenylephrine (PE) for 24 hours were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4°C, then were incubated with 0.35 µg/mL ab5245 for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with: no peptide (1), the non-phosphopeptide corresponding to the immunogen (2), a generic phosphoserine-containing peptide (3), or, the phosphopeptide immunogen (4). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase and signals were detected using the Tropix WesternStar method. The data show that only the peptide corresponding to GATA-4 [pS105] blocks the antibody signal, and that the S105A mutant does not react, thereby demonstrating the specificity of the antibody.
    Extracts prepared from cardiomyocytes o


This product has been referenced in:
  • Tae HJ  et al. G protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing ß1- and ß2-adrenergic receptors. Mol Med Rep 15:4049-4054 (2017). Read more (PubMed: 28487987) »
  • Tasoglu S  et al. Guided and magnetic self-assembly of tunable magnetoceptive gels. Nat Commun 5:4702 (2014). ICC/IF ; Rat . Read more (PubMed: 25175148) »

See all 10 Publications for this product

Customer reviews and Q&As

Thank you for your protocol details, I'm very sorry to hear you are experiencing problems with ab5245 and would like to recommend the following advice: 1) please make sure that the protein is in its phosphorylated form: do you have a stimulation pa...

Read More


Sign up